Screening for rheumatoid arthritis-associated interstitial lung disease using lung ultrasound: a systematic review and meta-analysis of recent studies
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Interstitial lung diseases (ILD) associated with systemic autoimmune disease can have a strong negative impact on patient outcomes. The diagnostic gold standard is high-resolution computer tomography (HRCT). Numerous studies have proven lung ultrasound's (LUS) utility in ILD, as well as other lung pathologies. Recently, there has been more focus on ILD in rheumatoid arthritis (RA), a previously overlooked complication, and screening methods. The purpose of this systematic review and meta-analysis was to summarize the recent knowledge regarding LUS compared to HRCT in screening ILD in RA patients. We reviewed relevant literature from the last 10 years and selected 12 articles. We included seven of those (totaling 756 patients) in a meta-analysis of diagnostic markers. The pooled sensitivity of LUS was 0.88 (95% CI 0.82-0.92) and pooled specificity was 0.86 (95% CI 0.71-0.94). The pooled LR+ and LR-were found to be 6.63 (95% CI 2.84-15.47) and 0.13 (95% CI 0.08-0.22), respectively. Diagnostic odds ratio was 48.54 (95% CI 13.78-170.98). LUS has high sensitivity and specificity for screening ILD in RA patients across different techniques and scoring systems.